News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sigma Pharmaceuticals Gets A$707 Million ($579 Million) Takeover Proposal
May 21, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
May 21 (Bloomberg) -- Sigma Pharmaceuticals Ltd., the unprofitable owner of the Guardian drugstore brand, received a A$707 million ($579 million) takeover proposal, 71 percent more than its market value.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Australia
MORE ON THIS TOPIC
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
April 23, 2026
·
2 min read
·
Nick Paul Taylor
Podcast
Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
April 22, 2026
·
1 min read
·
Heather McKenzie
Series A
Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs
April 21, 2026
·
1 min read
·
Gabrielle Masson
Mergers & acquisitions
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
April 20, 2026
·
2 min read
·
Annalee Armstrong
